NIMBLE ONCOLOGY Trademark

Trademark Overview

On Friday, September 16, 2016, a trademark application was filed for NIMBLE ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the NIMBLE ONCOLOGY trademark a serial number of 87173202. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 9, 2024. This trademark is owned by Boston Biopharma, Inc. The NIMBLE ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the fields of oncology, pharmaceutical research and development, laboratory testing, and diagnostics
nimble oncology

General Information

Serial Number87173202
Word MarkNIMBLE ONCOLOGY
Filing DateFriday, September 16, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 9, 2024
Registration Number5389256
Registration DateTuesday, January 30, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

NOT AVAILABLE"ONCOLOGY"
Goods and ServicesConsulting services in the fields of oncology, pharmaceutical research and development, laboratory testing, and diagnostics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 9, 2024
Primary Code042
First Use Anywhere DateTuesday, January 5, 2016
First Use In Commerce DateTuesday, January 5, 2016

Trademark Owner History

Party NameBOSTON BIOPHARMA HOLDING, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressALPHARETTA, GA 30009
Party NameBoston Biopharma, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30009
Party NameBoston Biopharma, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30009
Party NameBoston Biopharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30009

Trademark Events

Event DateEvent Description
Wednesday, September 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2016NEW APPLICATION ENTERED
Thursday, December 22, 2016ASSIGNED TO EXAMINER
Tuesday, January 3, 2017NON-FINAL ACTION WRITTEN
Tuesday, January 3, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 3, 2017NON-FINAL ACTION E-MAILED
Thursday, February 2, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 2, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 18, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 6, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 6, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, July 6, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Thursday, July 6, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, July 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 13, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, December 24, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 30, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 30, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 9, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, February 14, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

oncology nimble development laboratory testing diagnostics research pharmaceutical services fields consulting